Check this biotech stock out. The price of this stock exploded on the upside thanks to advancements in its cholesterol management drugs. It helped that Pfizer's own Lipitor replacement drug was cancelled due to a high amount of deaths during its clinical trials. Who knows, Pfizer might buy out this company to keep its product pipeline full. The charts say it all.

With all the fatties I see at the restaurants, I guess demand for these type of drugs will be strong.